Cargando…
Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets
Three-dimensional (3D) printing technology, specifically stereolithography (SLA) technology, has recently created exciting possibilities for the design and fabrication of sophisticated dosages for oral administration, paving a practical way to precisely manufacture customized pharmaceutical dosages...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541594/ https://www.ncbi.nlm.nih.gov/pubmed/34684010 http://dx.doi.org/10.3390/pharmaceutics13101717 |
_version_ | 1784589269058191360 |
---|---|
author | Xu, Lei Yang, Qingliang Qiang, Wei Li, Huijie Zhong, Weizhen Pan, Siying Yang, Gensheng |
author_facet | Xu, Lei Yang, Qingliang Qiang, Wei Li, Huijie Zhong, Weizhen Pan, Siying Yang, Gensheng |
author_sort | Xu, Lei |
collection | PubMed |
description | Three-dimensional (3D) printing technology, specifically stereolithography (SLA) technology, has recently created exciting possibilities for the design and fabrication of sophisticated dosages for oral administration, paving a practical way to precisely manufacture customized pharmaceutical dosages with both personalized properties and sustained drug release behavior. However, the sustained drug release achieved in prior studies largely relies on the presence of hydrophilic excipients in the printing formulation, which unfortunately impedes the printability and formability of the corresponding printing formulations. The current study developed and prepared mini-sized oral pellets using the SLA technique and successfully accomplished a hydrophilic excipient-independent drug release behavior. With ibuprofen as the model drug, the customized photopolymerizable printing formulation included polyethylene glycol diacrylate (PEGDA) as a monomer and diphenyl (2,4,6-trimethylbenzoyl) phosphine oxide (TPO) as a photoinitiator. The produced mini-sized pellets were thoroughly investigated for various factors, including their printability, physical properties, microscopic features, drug content, and drug-release profiles. The drug release profiles from the printed pellets that were larger size (3 mm and 6 mm) followed the Ritger–Peppas model, demonstrating that the release was influenced by both the diffusion of the dissolved drug and by the erosion of the hydrophilic excipients (PEG400). The profiles from the smaller printed pellets (1 mm and 2 mm) followed first release kinetics, not only illustrating that the release was impacted only by drug diffusion, but also indicating that there is a size boundary between the dependent and independent hydrophilic excipients. These results could create practical benefits to the pharmaceutical industry in terms of the design and development personalized dosages using the SLA printing technique with controllable drug release by manipulating size alone. |
format | Online Article Text |
id | pubmed-8541594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85415942021-10-24 Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets Xu, Lei Yang, Qingliang Qiang, Wei Li, Huijie Zhong, Weizhen Pan, Siying Yang, Gensheng Pharmaceutics Article Three-dimensional (3D) printing technology, specifically stereolithography (SLA) technology, has recently created exciting possibilities for the design and fabrication of sophisticated dosages for oral administration, paving a practical way to precisely manufacture customized pharmaceutical dosages with both personalized properties and sustained drug release behavior. However, the sustained drug release achieved in prior studies largely relies on the presence of hydrophilic excipients in the printing formulation, which unfortunately impedes the printability and formability of the corresponding printing formulations. The current study developed and prepared mini-sized oral pellets using the SLA technique and successfully accomplished a hydrophilic excipient-independent drug release behavior. With ibuprofen as the model drug, the customized photopolymerizable printing formulation included polyethylene glycol diacrylate (PEGDA) as a monomer and diphenyl (2,4,6-trimethylbenzoyl) phosphine oxide (TPO) as a photoinitiator. The produced mini-sized pellets were thoroughly investigated for various factors, including their printability, physical properties, microscopic features, drug content, and drug-release profiles. The drug release profiles from the printed pellets that were larger size (3 mm and 6 mm) followed the Ritger–Peppas model, demonstrating that the release was influenced by both the diffusion of the dissolved drug and by the erosion of the hydrophilic excipients (PEG400). The profiles from the smaller printed pellets (1 mm and 2 mm) followed first release kinetics, not only illustrating that the release was impacted only by drug diffusion, but also indicating that there is a size boundary between the dependent and independent hydrophilic excipients. These results could create practical benefits to the pharmaceutical industry in terms of the design and development personalized dosages using the SLA printing technique with controllable drug release by manipulating size alone. MDPI 2021-10-17 /pmc/articles/PMC8541594/ /pubmed/34684010 http://dx.doi.org/10.3390/pharmaceutics13101717 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Xu, Lei Yang, Qingliang Qiang, Wei Li, Huijie Zhong, Weizhen Pan, Siying Yang, Gensheng Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets |
title | Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets |
title_full | Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets |
title_fullStr | Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets |
title_full_unstemmed | Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets |
title_short | Hydrophilic Excipient-Independent Drug Release from SLA-Printed Pellets |
title_sort | hydrophilic excipient-independent drug release from sla-printed pellets |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541594/ https://www.ncbi.nlm.nih.gov/pubmed/34684010 http://dx.doi.org/10.3390/pharmaceutics13101717 |
work_keys_str_mv | AT xulei hydrophilicexcipientindependentdrugreleasefromslaprintedpellets AT yangqingliang hydrophilicexcipientindependentdrugreleasefromslaprintedpellets AT qiangwei hydrophilicexcipientindependentdrugreleasefromslaprintedpellets AT lihuijie hydrophilicexcipientindependentdrugreleasefromslaprintedpellets AT zhongweizhen hydrophilicexcipientindependentdrugreleasefromslaprintedpellets AT pansiying hydrophilicexcipientindependentdrugreleasefromslaprintedpellets AT yanggensheng hydrophilicexcipientindependentdrugreleasefromslaprintedpellets |